Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and Irinotecan vs Irinotecan in Refractory Pancreatic Cancer
NCT02558868Phase 2Completed
- Sponsor
- Zhejiang University
- Start
- Sep 2015
- Primary completion
- Sep 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in pancreatic cancer (PC), sponsored by Zhejiang University. Started Sep 2015; status: completed.
02
Drugs
oxaliplatin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02558868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02558868.